The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors

Veronika Binder, Senka Ljubojevic, Johannes Haybaeck, Michael Holzer, Dalia El-Gamal, Rudolf Schicho, Burkert Pieske, Akos Heinemann, Gunther Marsche

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

OBJECTIVE - : Elevated levels of advanced oxidation protein products have been described in several chronic inflammatory diseases, like chronic renal insufficiency, rheumatoid arthritis, and atherosclerosis. Recent findings revealed that advanced oxidation protein products are inhibitors of the major high-density lipoprotein receptor, scavenger receptor class B, type 1 (SR-BI). Here, we investigated which oxidation-induced structural alterations convert plasma albumin into a high-density lipoprotein-receptor inhibitor. APPROACH AND RESULTS - : Exposure of albumin to the physiological oxidant, hypochlorous acid, generated high-affinity SR-BI ligands. Protection of albumin-lysine residues before exposure to hypochlorous acid as well as regeneration of N-chloramines after oxidation of albumin completely prevented binding of oxidized albumin to SR-BI, indicating that modification of albumin-lysine residues is required to generate SR-BI ligands. Of particular interest, N-chloramines within oxidized albumin promoted irreversible binding to SR-BI, resulting in permanent receptor blockade. We observed that the SR-BI inhibitory activity of albumin isolated from chronic kidney disease patients correlated with the content of the myeloperoxidase-specific oxidation product 3-chlorotyrosine and was associated with alterations in the composition of high-density lipoprotein. CONCLUSIONS - : Given that several potential atheroprotective activities of high-density lipoprotein are mediated by SR-BI, the present results raise the possibility that oxidized plasma albumin, through permanent SR-BI blockade, contributes to the pathophysiology of cardiovascular disease.

Original languageEnglish (US)
Pages (from-to)1020-1027
Number of pages8
JournalArteriosclerosis, Thrombosis, and Vascular Biology
Volume33
Issue number5
DOIs
StatePublished - May 1 2013

Fingerprint

Hypochlorous Acid
Peroxidase
Albumins
Chloramines
Advanced Oxidation Protein Products
HDL Lipoproteins
Chronic Renal Insufficiency
Serum Albumin
Lysine
CD36 Antigens
Ligands
high density lipoprotein receptors
Oxidants
Regeneration
Rheumatoid Arthritis
Atherosclerosis
Chronic Disease
Cardiovascular Diseases

Keywords

  • advanced oxidation protein products
  • atherosclerosis
  • end-stage renal disease
  • high-density lipoprotein- metabolism
  • high-density lipoprotein-composition
  • myeloperoxidase
  • scavenger receptor class B, type 1

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors. / Binder, Veronika; Ljubojevic, Senka; Haybaeck, Johannes; Holzer, Michael; El-Gamal, Dalia; Schicho, Rudolf; Pieske, Burkert; Heinemann, Akos; Marsche, Gunther.

In: Arteriosclerosis, Thrombosis, and Vascular Biology, Vol. 33, No. 5, 01.05.2013, p. 1020-1027.

Research output: Contribution to journalArticle

Binder, Veronika ; Ljubojevic, Senka ; Haybaeck, Johannes ; Holzer, Michael ; El-Gamal, Dalia ; Schicho, Rudolf ; Pieske, Burkert ; Heinemann, Akos ; Marsche, Gunther. / The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors. In: Arteriosclerosis, Thrombosis, and Vascular Biology. 2013 ; Vol. 33, No. 5. pp. 1020-1027.
@article{c3202af500ea4072a3d579c31a6697a7,
title = "The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors",
abstract = "OBJECTIVE - : Elevated levels of advanced oxidation protein products have been described in several chronic inflammatory diseases, like chronic renal insufficiency, rheumatoid arthritis, and atherosclerosis. Recent findings revealed that advanced oxidation protein products are inhibitors of the major high-density lipoprotein receptor, scavenger receptor class B, type 1 (SR-BI). Here, we investigated which oxidation-induced structural alterations convert plasma albumin into a high-density lipoprotein-receptor inhibitor. APPROACH AND RESULTS - : Exposure of albumin to the physiological oxidant, hypochlorous acid, generated high-affinity SR-BI ligands. Protection of albumin-lysine residues before exposure to hypochlorous acid as well as regeneration of N-chloramines after oxidation of albumin completely prevented binding of oxidized albumin to SR-BI, indicating that modification of albumin-lysine residues is required to generate SR-BI ligands. Of particular interest, N-chloramines within oxidized albumin promoted irreversible binding to SR-BI, resulting in permanent receptor blockade. We observed that the SR-BI inhibitory activity of albumin isolated from chronic kidney disease patients correlated with the content of the myeloperoxidase-specific oxidation product 3-chlorotyrosine and was associated with alterations in the composition of high-density lipoprotein. CONCLUSIONS - : Given that several potential atheroprotective activities of high-density lipoprotein are mediated by SR-BI, the present results raise the possibility that oxidized plasma albumin, through permanent SR-BI blockade, contributes to the pathophysiology of cardiovascular disease.",
keywords = "advanced oxidation protein products, atherosclerosis, end-stage renal disease, high-density lipoprotein- metabolism, high-density lipoprotein-composition, myeloperoxidase, scavenger receptor class B, type 1",
author = "Veronika Binder and Senka Ljubojevic and Johannes Haybaeck and Michael Holzer and Dalia El-Gamal and Rudolf Schicho and Burkert Pieske and Akos Heinemann and Gunther Marsche",
year = "2013",
month = "5",
day = "1",
doi = "10.1161/ATVBAHA.113.301235",
language = "English (US)",
volume = "33",
pages = "1020--1027",
journal = "Arteriosclerosis, Thrombosis, and Vascular Biology",
issn = "1079-5642",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - The myeloperoxidase product hypochlorous acid generates irreversible high-density lipoprotein receptor inhibitors

AU - Binder, Veronika

AU - Ljubojevic, Senka

AU - Haybaeck, Johannes

AU - Holzer, Michael

AU - El-Gamal, Dalia

AU - Schicho, Rudolf

AU - Pieske, Burkert

AU - Heinemann, Akos

AU - Marsche, Gunther

PY - 2013/5/1

Y1 - 2013/5/1

N2 - OBJECTIVE - : Elevated levels of advanced oxidation protein products have been described in several chronic inflammatory diseases, like chronic renal insufficiency, rheumatoid arthritis, and atherosclerosis. Recent findings revealed that advanced oxidation protein products are inhibitors of the major high-density lipoprotein receptor, scavenger receptor class B, type 1 (SR-BI). Here, we investigated which oxidation-induced structural alterations convert plasma albumin into a high-density lipoprotein-receptor inhibitor. APPROACH AND RESULTS - : Exposure of albumin to the physiological oxidant, hypochlorous acid, generated high-affinity SR-BI ligands. Protection of albumin-lysine residues before exposure to hypochlorous acid as well as regeneration of N-chloramines after oxidation of albumin completely prevented binding of oxidized albumin to SR-BI, indicating that modification of albumin-lysine residues is required to generate SR-BI ligands. Of particular interest, N-chloramines within oxidized albumin promoted irreversible binding to SR-BI, resulting in permanent receptor blockade. We observed that the SR-BI inhibitory activity of albumin isolated from chronic kidney disease patients correlated with the content of the myeloperoxidase-specific oxidation product 3-chlorotyrosine and was associated with alterations in the composition of high-density lipoprotein. CONCLUSIONS - : Given that several potential atheroprotective activities of high-density lipoprotein are mediated by SR-BI, the present results raise the possibility that oxidized plasma albumin, through permanent SR-BI blockade, contributes to the pathophysiology of cardiovascular disease.

AB - OBJECTIVE - : Elevated levels of advanced oxidation protein products have been described in several chronic inflammatory diseases, like chronic renal insufficiency, rheumatoid arthritis, and atherosclerosis. Recent findings revealed that advanced oxidation protein products are inhibitors of the major high-density lipoprotein receptor, scavenger receptor class B, type 1 (SR-BI). Here, we investigated which oxidation-induced structural alterations convert plasma albumin into a high-density lipoprotein-receptor inhibitor. APPROACH AND RESULTS - : Exposure of albumin to the physiological oxidant, hypochlorous acid, generated high-affinity SR-BI ligands. Protection of albumin-lysine residues before exposure to hypochlorous acid as well as regeneration of N-chloramines after oxidation of albumin completely prevented binding of oxidized albumin to SR-BI, indicating that modification of albumin-lysine residues is required to generate SR-BI ligands. Of particular interest, N-chloramines within oxidized albumin promoted irreversible binding to SR-BI, resulting in permanent receptor blockade. We observed that the SR-BI inhibitory activity of albumin isolated from chronic kidney disease patients correlated with the content of the myeloperoxidase-specific oxidation product 3-chlorotyrosine and was associated with alterations in the composition of high-density lipoprotein. CONCLUSIONS - : Given that several potential atheroprotective activities of high-density lipoprotein are mediated by SR-BI, the present results raise the possibility that oxidized plasma albumin, through permanent SR-BI blockade, contributes to the pathophysiology of cardiovascular disease.

KW - advanced oxidation protein products

KW - atherosclerosis

KW - end-stage renal disease

KW - high-density lipoprotein- metabolism

KW - high-density lipoprotein-composition

KW - myeloperoxidase

KW - scavenger receptor class B, type 1

UR - http://www.scopus.com/inward/record.url?scp=84876295516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84876295516&partnerID=8YFLogxK

U2 - 10.1161/ATVBAHA.113.301235

DO - 10.1161/ATVBAHA.113.301235

M3 - Article

C2 - 23493288

AN - SCOPUS:84876295516

VL - 33

SP - 1020

EP - 1027

JO - Arteriosclerosis, Thrombosis, and Vascular Biology

JF - Arteriosclerosis, Thrombosis, and Vascular Biology

SN - 1079-5642

IS - 5

ER -